1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Illinois >
  6. Matinas BioPharma Holdings Acquires Aquarius BioTechnologies

M&A Deal Summary

Matinas BioPharma Holdings Acquires Aquarius BioTechnologies

On January 30, 2015, Matinas BioPharma Holdings acquired life science company Aquarius BioTechnologies

Acquisition Highlights
  • This is Matinas BioPharma Holdings’ 1st transaction in the Life Science sector.
  • This is Matinas BioPharma Holdings’ 1st transaction in the United States.
  • This is Matinas BioPharma Holdings’ 1st transaction in Illinois.

M&A Deal Summary
Date 2015-01-30
Target Aquarius BioTechnologies
Sector Life Science
Buyer(s) Matinas BioPharma Holdings
Deal Type Add-on Acquisition

Target

Aquarius BioTechnologies

Chicago, Illinois, United States
Aquarius BioTechnologies, Inc. is an innovative bio-delivery drug discovery company with a novel and proprietary lipid-crystal nano-particle cochleate formulation technology platform.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Matinas BioPharma Holdings

Bedminster, New Jersey, United States
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It focus on identifying and developing novel lipid-based pharmaceutical products for the treatment cardiovascular and metabolic conditions and infectious diseases.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Illinois M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal